Vitamin-Carrying Protein Pathway Shows Promise for Brain Drug Delivery
Researchers say the transporter could improve brain delivery of creatine and other therapies by using the blood-brain barrier’s own transport systems.
7 Articles
7 Articles
Vitamin-carrying protein pathway shows promise for brain drug delivery
Researchers at the University of Eastern Finland have identified a transporter protein with the potential to open new avenues for improving creatine delivery into the brain and for developing other therapies targeting the central nervous system.
Novel transporter protein discovery opens new pathways for central nervous system therapies
Researchers at the University of Eastern Finland have identified a transporter protein with the potential to open new avenues for improving creatine delivery into the brain and for developing other therapies targeting the central nervous system.
Targeting the Blood-Brain Barrier Using Sodium-Dependent Multivitamin Transporter Protein Systems
Researchers at the University of Eastern Finland have identified a transporter protein with the potential to open new avenues for improving creatine delivery into the brain and for developing other therapies targeting the central nervous system.
Oral creatine barely reaches the brain via the SLC6A8 transporter. Finnish derivatives use the SMVT pathway to strain it and fine-tune the focus. The entry Creatine and the brain: why the oral dose yields little in the focus and which derivatives are investigated aparece primero en Merca2.
New Transporter Bypasses Blood-Brain Barrier to Deliver Creatine
How can drugs bypass the brain's tightest security checkpoint? Researchers at the University of Eastern Finland discovered that hijacking the sodium-dependent multivitamin transporter (SMVT) allows creatine derivatives to cross the blood-brain barrier, offering hope for rare deficiency syndromes.
University of Eastern Finland researchers identify transporter protein - Archyworldys
Researchers at the University of Eastern Finland identified a transporter protein in 2026 that opens new avenues for improving creatine delivery into the brain and developing therapies targeting the central nervous system. Published in ACS Chemical Neuroscience, the study investigated the sodium-dependent multivitamin transporter (SMVT) to target creatine derivatives across the blood-brain barrier, which normally ...
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium










